| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |